Discover trends, market shifts, and competitive outlooks for the peanut allergy treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Peanut Allergy Treatment Market Size From 2025 to 2034?

The market for treating peanut allergies has seen a significant expansion in the recent past. The market which was valued at $0.45 billion in 2024, is forecasted to rise to $0.51 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. This growth in the previous years was driven by several factors like a surge in the incidence of the allergy, improvements in testing methods, increased public understanding and anxiety, the creation of early response strategies, and regulatory permissions for treatments of peanut allergies.

The market for treatment of peanut allergies is anticipated to witness a significant surge in the coming years, potentially reaching $0.77 billion by 2029, with a compound annual growth rate (CAGR) of 11.1%. This growth is largely ascribed to the increasing prevalence of the condition, the rise of personalized medicine, the emergence of innovative immunotherapy treatments, boosted private and public funding, as well as the advancement of telemedicine. The prediction period is characterized by distinct trends such as the growing acceptance of immunotherapy, evolution in biologic therapies, usage of probiotics in treatments, breakthroughs in delivery system technology, personalized medical strategies, and regulatory ratifications and backing.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15888&type=smp

Which Primay Drivers Are Accelerating Growth in the Peanut Allergy Treatment Market?

Investments dedicated to Research and Development (R&D) in allergy remediation are anticipated to spur the expansion of the peanut allergy treatment market. R&D investment pertains to the financial contribution made by corporations, organizations, or governments to facilitate activities that promote innovation, product growth, and technology advancement, and it is integral to progressing peanut allergy treatments. This financial commitment encourages the development of pioneering desensitization methods and immunotherapies, with the goal to diminish allergic reactions and enhance the life quality of individuals living with peanut allergies. For example, the Victorian Government revealed a strategic investment of $12 million in Aravax, a clinical-stage biotech firm based in Australia, in January 2024 to considerably progress global peanut allergy treatment. This investment is a part of a wider $66 million round focusing on the development of Aravax’s ground-breaking immunotherapy, PVX108. Both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA) have granted this initiative Phase 2 trial approvals, emphasizing its potential influence on global public health. Hence, R&D investment in allergy treatments is propelling the growth of the peanut allergy treatment market.

How Is the Peanut Allergy Treatment Market Segmented?

The peanut allergy treatment market covered in this report is segmented –

1) By Drug Class: Antihistamines, Immunotherapies, Epinephrine, Other Drug Classes

2) By Route Of Administration: Injectable, Oral, Other Routes Of Administration

3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels

Subsegments:

1) By Antihistamines: Oral Antihistamines, Topical Antihistamines

2) By Immunotherapies: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)

3) By Epinephrine: Epinephrine Auto-Injectors, Epinephrine Inhalers

4) By Other Drug Classes: Leukotriene Receptor Antagonists, Monoclonal Antibodies, Corticosteroids

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15888&type=smp

Which Regions Are Key Players in the Growth of the Peanut Allergy Treatment Market?

North America was the largest region in the peanut allergy treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peanut allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Technological Trends Are Reshaping the Peanut Allergy Treatment Industry Dynamics?

Prominent enterprises in the peanut allergy treatment market are concentrating on bioscience related therapeutic developments, specifically anti-IgE monoclonal antibodies, to provide more efficient and targeted solutions for peanut allergy control. Their ultimate goal is to enhance the patient’s overall well-being and life quality. Anti-IgE monoclonal antibodies are specially crafted therapeutic agents used to neutralize specific antibodies, termed immunoglobulin E, in the human body. For example, Novartis Pharmaceuticals Corporation, originating from Switzerland, was granted approval for Xolair (omalizumab) by the FDA in February 2024. This drug aims to reduce allergic responses, such as anaphylaxis in patients aged 1 or older suffering from IgE-mediated food allergies. The approval was based on the results of the Phase III OUtMATCH study funded by NIH, which demonstrated significant enhancement in food allergy resistance in Xolair-treated patients as opposed to those who received a placebo.

View the full report here:

https://www.thebusinessresearchcompany.com/report/peanut-allergy-treatment-global-market-report

How Is the Peanut Allergy Treatment Market Defined and What Are Its Core Parameters?

Peanut allergy treatment refers to various medical approaches designed to manage and reduce the severity of allergic reactions to peanuts. These treatments involve various approaches, such as epicutaneous immunotherapy and biologic therapies aimed at desensitizing individuals to peanuts and mitigating allergic reactions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15888

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model